A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression

NCT05196971 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment Resistant Depressive Disorder

Interventions

DRUG: HS-10345 84mg
DRUG: Placebo

Sponsor

Jiangsu Hansoh Pharmaceutical Co., Ltd.